Taking Stock
Rx Savings' Rea on Wide Gaps in EpiPen Drug Pricing (Audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:45
- Mas informaciones
Informações:
Sinopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) and the US ($600.)
